Growth Metrics

Guardant Health (GH) Gains from Investment Securities (2017 - 2026)

Guardant Health's Gains from Investment Securities history spans 8 years, with the latest figure at $16.0 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 541.9% to $16.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $41.2 million, a 3993.74% increase, with the full-year FY2025 number at $41.2 million, up 3993.74% from a year prior.
  • Gains from Investment Securities hit $16.0 million in Q4 2025 for Guardant Health, up from $2.3 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for GH hit a ceiling of $83.6 million in Q4 2021 and a floor of -$5.4 million in Q3 2023.
  • Historically, Gains from Investment Securities has averaged $7.0 million across 5 years, with a median of $993000.0 in 2023.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 181333.33% in 2023 and later surged 1836.39% in 2025.
  • Tracing GH's Gains from Investment Securities over 5 years: stood at $83.6 million in 2021, then crashed by 94.82% to $4.3 million in 2022, then plummeted by 46.79% to $2.3 million in 2023, then rose by 8.51% to $2.5 million in 2024, then surged by 541.9% to $16.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for GH at $16.0 million in Q4 2025, $2.3 million in Q3 2025, and $23.9 million in Q2 2025.